本頁面由Tiger Trade Technology Pte. Ltd.提供服務

XORTX Therapeutics Inc.

2.00
-0.0400-1.96%
盤後2.000.00000.00%19:56 EDT
成交量:1,084
成交額:2,138.73
市值:363.31萬
市盈率:-0.73
高:2.00
開:2.00
低:1.88
收:2.04
52周最高:7.05
52周最低:1.73
股本:181.66萬
流通股本:178.94萬
量比:0.22
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-2.7455
每股收益(LYR):-2.8052
淨資產收益率:-99.24%
總資產收益率:-29.85%
市淨率:0.66
市盈率(LYR):-0.71

資料載入中...

2026/03/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/02/13

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/02/13

SEC問詢函

Form CORRESP - Correspondence
2025/09/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/05/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/15

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/05/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2023/01/27

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/22

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/22

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/21

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/21

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/09/19

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/19

SEC問詢函

CORRESP [Cover] - Correspondence